Humanigen Inc (HGENQ)

[cowtown jay]

It made sense to me, as I said in a previous post, to transfer the IP rights to Taran to safeguard the IP in the event that the bankruptcy court judge converted the case to CH7, in which case the IP would have been included in the sale.

Did Humanigen have entitlement to sells revenue earned by our Korean partner, simply because we owned the IP? No.

Nor would Taran have entitlement to sells revenue earned by Humanigen.

We just haven't see the details yet regarding licensing, or a possible merger. What we DO know is that Taran did not submit a tender offer to buy Humanigen, which is the only way Taran could claim sells revenue. But again, as Asset Purchase Agreement is not a buy-out.